Use filters to refine the search results.
Results 1-4 of 4
|10-Feb-2021||SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.||Ward, H; Atchison, C; Whitaker, M; Ainslie, KEC; Elliott, J, et al|
|12-Aug-2020||Usability and acceptability of home-based self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibodies for population surveillance||Atchison, C; Pristerà, P; Cooper, E; Papageorgiou, V; Redd, R, et al|
|Apr-2022||SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys||Chadeau-Hyam, M; Wang, H; Eales, O; Haw, D; Bodinier, B, et al|
|28-Sep-2021||Predictive symptoms for COVID-19 in the community: REACT-1 study of over one million people||Elliott, J; Whitaker, M; Bodinier, B; Eales, O; Riley, S, et al|